Mari E. Strand

724 total citations
16 papers, 532 citations indexed

About

Mari E. Strand is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Pharmacology. According to data from OpenAlex, Mari E. Strand has authored 16 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Mari E. Strand's work include Cardiac Fibrosis and Remodeling (9 papers), Cardiac Valve Diseases and Treatments (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Mari E. Strand is often cited by papers focused on Cardiac Fibrosis and Remodeling (9 papers), Cardiac Valve Diseases and Treatments (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Mari E. Strand collaborates with scholars based in Norway, United States and United Kingdom. Mari E. Strand's co-authors include Ida G. Lunde, Geir Christensen, Ivar Sjaastad, Christen P. Dahl, Biljana Skrbic, Theis Tønnessen, Kristin V. T. Engebretsen, Åsa Hammar, Jan Magnus Aronsen and Henriette S. Marstein and has published in prestigious journals such as PLoS ONE, Scientific Reports and European Heart Journal.

In The Last Decade

Mari E. Strand

16 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mari E. Strand Norway	12	238	174	103	76	73	16	532
Qiuling Xiang China	12	133 0.6×	181 1.0×	24 0.2×	94 1.2×	50 0.7×	26	500
Yanqing Hu China	11	271 1.1×	110 0.6×	44 0.4×	72 0.9×	29 0.4×	25	555
Chang-Sub Uhm South Korea	12	385 1.6×	340 2.0×	96 0.9×	95 1.3×	44 0.6×	18	860
Ka Chun Suen United Kingdom	6	62 0.3×	149 0.9×	15 0.1×	68 0.9×	96 1.3×	6	656
Stefanie Heilmann‐Heimbach Germany	16	31 0.1×	344 2.0×	120 1.2×	49 0.6×	26 0.4×	65	826
Alisher R. Dadabayev United States	9	32 0.1×	125 0.7×	32 0.3×	50 0.7×	169 2.3×	12	496
Ana María Fortuna Portugal	14	24 0.1×	330 1.9×	70 0.7×	46 0.6×	41 0.6×	45	834
M. Bauer Germany	8	73 0.3×	116 0.7×	19 0.2×	53 0.7×	12 0.2×	11	420
Bénédicte Prunet‐Marcassus France	7	29 0.1×	121 0.7×	17 0.2×	107 1.4×	32 0.4×	7	578
Hiroyuki Nakayasu Japan	12	46 0.2×	163 0.9×	42 0.4×	36 0.5×	15 0.2×	52	535

Countries citing papers authored by Mari E. Strand

Since Specialization

Citations

This map shows the geographic impact of Mari E. Strand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari E. Strand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari E. Strand more than expected).

Fields of papers citing papers by Mari E. Strand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari E. Strand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari E. Strand. The network helps show where Mari E. Strand may publish in the future.

Co-authorship network of co-authors of Mari E. Strand

This figure shows the co-authorship network connecting the top 25 collaborators of Mari E. Strand. A scholar is included among the top collaborators of Mari E. Strand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari E. Strand. Mari E. Strand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Strand, Mari E., Maarten Vanhaverbeke, Michiel T.H.M. Henkens, et al.. (2023). Inflammation and Syndecan-4 Shedding from Cardiac Cells in Ischemic and Non-Ischemic Heart Disease. Biomedicines. 11(4). 1066–1066. 7 indexed citations

Lunde, Ida G., Jan Magnus Aronsen, Arne Olav Melleby, et al.. (2022). Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy. Molecular Biology Reports. 49(12). 11795–11809. 11 indexed citations

Erusappan, Pugazendhi M, Arne Olav Melleby, Mari E. Strand, et al.. (2021). The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts. Scientific Reports. 11(1). 19757–19757. 27 indexed citations

Lunde, Ida G., Mari E. Strand, Jan Magnus Aronsen, et al.. (2019). The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload. Scientific Reports. 9(1). 9206–9206. 41 indexed citations

Lunde, Ida G., Christen P. Dahl, Jan Magnus Aronsen, et al.. (2018). The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling. PLoS ONE. 13(7). e0201422–e0201422. 48 indexed citations

Lunde, Ida G., Mari E. Strand, Jan Magnus Aronsen, et al.. (2017). 5924Lack of the extracellular matrix proteoglycan lumican in mice exacerbates left ventricular dilatation and contractile dysfunction upon pressure overload. European Heart Journal. 38(suppl_1). 1 indexed citations

Melleby, Arne Olav, Mari E. Strand, Andreas Romaine, et al.. (2016). The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling. PLoS ONE. 11(10). e0165079–e0165079. 25 indexed citations

Skrbic, Biljana, Kristin V. T. Engebretsen, Mari E. Strand, et al.. (2015). Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice†. Cardiovascular Research. 106(1). 32–42. 51 indexed citations

Strand, Mari E., Jan Magnus Aronsen, Ivar Sjaastad, et al.. (2015). Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice. Journal of Molecular and Cellular Cardiology. 88. 133–144. 51 indexed citations

10.

Engebretsen, Kristin V. T., Ida G. Lunde, Mari E. Strand, et al.. (2013). Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. FEBS Journal. 280(10). 2382–2398. 85 indexed citations

11.

Askevold, Erik T., Pål Aukrust, Ståle H. Nymo, et al.. (2013). The cardiokine secreted Frizzled‐related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure. Journal of Internal Medicine. 275(6). 621–630. 39 indexed citations

12.

Strand, Mari E., Kate M. Herum, Zaheer A. Rana, et al.. (2013). Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan‐4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure‐overloaded heart. FEBS Journal. 280(10). 2228–2247. 71 indexed citations

13.

Strand, Mari E., Bjørn Sætrevik, Anders Lund, & Åsa Hammar. (2012). The relationship between residual symptoms of depression and emotional information processing. Nordic Journal of Psychiatry. 67(4). 233–239. 4 indexed citations

14.

Strand, Mari E., Mike W. Oram, & Åsa Hammar. (2012). Emotional Information Processing in Major Depression Remission and Partial Remission: Faces Come First. Applied Neuropsychology Adult. 20(2). 110–119. 19 indexed citations

15.

Hammar, Åsa, et al.. (2011). Patients with Major Depression Show Intact Memory Performance—Given Optimal Conditions. Applied Neuropsychology. 18(3). 191–196. 13 indexed citations

16.

Hammar, Åsa, et al.. (2010). Testing the cognitive effort hypothesis of cognitive impairment in major depression. Nordic Journal of Psychiatry. 65(1). 74–80. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact